project id: TCGA-UCEC; case submitter id: TCGA-QS-A8F1; source center: 23; state: released; a260 a280 ratio: 1.7; concentration: 0.15; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.0; age at index: 85; days to birth: -31386; days to death: 135; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1928; age at diagnosis: 31386; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 125.0; figo stage: Stage IIIA; icd 10 code: C54.3; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus uteri; synchronous malignancy: No; tissue or organ of origin: Fundus uteri; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 29; days to sample procurement: 0; initial weight: 250.0; portion submitter id: TCGA-QS-A8F1-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 1.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;